Rf. Santos et al., EFFECT OF METFORMIN ON INSULIN-STIMULATED TYROSINE KINASE-ACTIVITY OFERYTHROCYTES FROM OBESE WOMEN WITH NORMAL GLUCOSE-TOLERANCE, Diabetes & metabolism, 23(2), 1997, pp. 143-148
The purpose of this study was to document the possible effect of solub
ilised erythrocytes on insulin-receptor binding and tyrosine kinase ac
tivity after 12 weeks of metformin administration to 13 healthy obese
women with no history of diabetes and normal glucose as evaluated by c
onventional criteria. Subjects were given metformin 850 mg twice a day
for 12 weeks. The results showed that plasma glucose response to an o
ral glucose challenge did not change following metformin, but that ins
ulin response was significantly lower (p < 0.0001). In addition, both
the number of insulin receptors and the tyrosine kinase activity per r
eceptor of solubilised erythrocytes were significantly greater followi
ng metformin administration. Since both body weight and plasma glucose
concentrations were similar before and after treatment, the effect of
metformin on insulin-receptor binding and tyrosine kinase activity ap
peared to be independent of either of these variables. In summary, ora
l administration of metformin led to an increase in tyrosine kinase ac
tivity or erythrocyte insulin receptors, suggesting that such action o
ccurs in the absence of any significant change in plasma glucose conce
ntration.